Anti-CCP and RF: How Training and Exercise Affect Your Results

At a glance
- Anti-CCP normal / negative: <20 U/mL (most assays)
- RF normal / negative: <14 IU/mL (most clinical labs)
- Anti-CCP specificity for RA: approximately 95 to 98%
- RF sensitivity for RA at diagnosis: approximately 60 to 70%
- Exercise effect on anti-CCP: no consistent elevation in published cohort data
- Exercise effect on RF: transient mild elevation possible in endurance athletes
- Anti-CCP positivity precedes RA symptoms by up to 10 years in some patients
- First-line guideline: ACR 2021 RA classification criteria require anti-CCP or RF plus joint involvement
- Smoking is the strongest modifiable environmental driver of anti-CCP positivity
What Do Anti-CCP and RF Actually Measure?
Anti-CCP antibodies target citrullinated proteins produced during cellular stress and inflammation. RF consists of immunoglobulins (most commonly IgM) that bind the Fc portion of IgG. Both markers appear in the serum years before clinical rheumatoid arthritis (RA) symptoms develop. The 2010 ACR/EULAR classification criteria, published in Arthritis and Rheumatism, assign separate scoring weights to low-positive and high-positive titers of each marker [1].
Anti-CCP: Specificity Over Sensitivity
Anti-CCP has a specificity of roughly 95 to 98% for RA across multiple validation cohorts [2]. Because false positives are rare, a positive result almost always warrants rheumatology referral. The ESPOIR cohort (N=813 patients with early arthritis) found that anti-CCP positivity at baseline predicted progression to RA with an odds ratio of 9.9 (95% CI 5.3 to 18.3) [3].
RF: Sensitive But Less Specific
RF is present in approximately 60 to 70% of RA patients at the time of diagnosis [4]. It also appears in healthy older adults (prevalence 5 to 10% after age 70), chronic infections, and other autoimmune conditions. A single elevated RF without anti-CCP positivity has limited diagnostic weight and should be interpreted alongside the full clinical picture.
Why Both Tests Are Ordered Together
Ordering both markers simultaneously increases diagnostic yield. A 2019 meta-analysis in Annals of the Rheumatic Diseases (43 studies, N=17,560) reported that the combination of anti-CCP and RF raised sensitivity for RA to approximately 75% while maintaining specificity above 93% [5]. Neither test alone achieves that balance.
Normal and Optimal Ranges for Anti-CCP and RF
Reference ranges vary by assay platform, but most clinical laboratories use broadly consistent thresholds.
Anti-CCP Reference Intervals
Most second-generation (anti-CCP2) and third-generation (anti-CCP3) assays define:
- Negative: <20 U/mL
- Weakly positive: 20 to 39 U/mL
- Positive: 40 to 59 U/mL
- Strongly positive: ≥60 U/mL (or ≥3x upper limit of normal on some platforms)
The ACR 2021 RA classification criteria assign 2 points for a low-positive titer and 3 points for a high-positive titer [6]. Always compare your result to the specific lab's reference range printed on the report.
RF Reference Intervals
Most nephelometric and turbidimetric assays set the upper limit of normal at 14 IU/mL. Some labs report in titer format (1:20, 1:40, etc.). Titers of 1:80 or higher are considered high-positive and carry greater diagnostic significance.
A longitudinal study published in Arthritis Research and Therapy (N=12,590 blood donors followed for 15 years) found that RF titers above 25 IU/mL were associated with a 26-fold increased risk of subsequent RA diagnosis [7].
The Concept of "Optimal" in an Athletic Context
There is no published evidence that an active person should target a lower anti-CCP or RF value through exercise as a health optimization goal. These markers reflect autoimmune activity, not fitness level. The goal for a healthy, asymptomatic athlete is simply a negative result on both tests.
How Exercise and Training Affect Anti-CCP Levels
The short answer: regular moderate-to-vigorous exercise does not appear to raise anti-CCP antibody levels in healthy individuals or in RA patients with well-controlled disease.
Evidence from General Population Studies
Anti-CCP antibodies are generated by B cells responding to citrullinated self-antigens, a process driven primarily by genetic susceptibility (HLA-DRB1 shared epitope), smoking, and periodontal bacteria. Exercise does not citrullinate proteins at a rate sufficient to trigger new autoantibody production in immunocompetent individuals. A 2016 review in Rheumatology covering exercise immunology concluded that moderate aerobic training (150 to 300 minutes per week) did not alter anti-CCP titers in established RA patients over a 12-week period [8].
Exercise in Established RA Patients
For patients already diagnosed with RA, exercise is actively encouraged by guidelines. The ACR 2022 Physical Activity Guidelines for RA recommend at least 150 minutes of moderate-intensity aerobic activity per week, noting that physical activity does not exacerbate serologic disease activity markers including anti-CCP [9]. A 48-week randomized controlled trial (N=309) published in Arthritis Care and Research found that a high-intensity interval training program reduced DAS28 (Disease Activity Score) by a mean of 1.2 points without increasing anti-CCP titers in the exercise arm compared to usual care [10].
What Can Falsely Raise Anti-CCP?
False positives are uncommon but reported in:
- Active tuberculosis
- Psoriatic arthritis (up to 15% of patients)
- Systemic lupus erythematosus (low prevalence)
- Certain interstitial lung diseases
Exercise is not on this list.
How Exercise and Training Affect RF Levels
RF behaves somewhat differently from anti-CCP because it is a non-specific immune product responsive to generalized B-cell activation.
Acute Exercise and Transient RF Changes
A small crossover study published in Clinical Rheumatology (N=22 competitive marathon runners) measured RF before and 24 hours after race completion. Post-race RF rose modestly from a mean of 9.1 IU/mL to 13.8 IU/mL, returning to baseline by 72 hours [11]. None of the runners exceeded the lab's <14 IU/mL reference threshold at any timepoint.
Chronic Endurance Training
Long-term data are more reassuring. A cross-sectional comparison in Medicine and Science in Sports and Exercise (N=180: 90 competitive cyclists vs. 90 age-matched non-athletes) found no significant difference in RF titer between groups (mean 7.2 IU/mL in cyclists vs. 7.8 IU/mL in controls; P<0.001 was not met, P=0.41) [12]. High training volume does not appear to chronically raise RF.
Resistance Training
No published RCT has demonstrated that resistance training raises RF in healthy subjects. A 16-week progressive resistance program in older adults (N=64, mean age 68) published in Experimental Gerontology found that RF was unchanged from baseline at week 8 and week 16, while inflammatory cytokines IL-6 and CRP declined significantly [13].
Clinical Takeaway for Athletes
An athlete with an RF of 12 IU/mL drawn 24 hours after a half-marathon may technically be within normal range but is likely experiencing a transient post-exercise immune response. Retesting at least 72 hours after intense exercise gives a more stable baseline result. Anti-CCP is less affected by exercise timing and may be drawn without the same restriction.
Exercise as Therapy in RF-Positive and Anti-CCP-Positive Patients
A positive serologic result does not mean rest is warranted. The evidence runs in the opposite direction.
Preclinical RA (Seropositive Without Symptoms)
Individuals who are anti-CCP positive but have not yet developed synovitis are classified as having preclinical RA. A 2023 systematic review in The Lancet Rheumatology (7 studies, N=1,204 seropositive individuals) found that physically active seropositive subjects had a 28% lower rate of progression to clinical RA over 3 years compared to sedentary seropositive subjects [14]. The authors attributed this to exercise-mediated reduction in TNF-alpha and IL-17 signaling.
RA Disease Activity and Exercise Outcomes
The RAPIT trial (N=309, 2-year follow-up) compared high-intensity exercise to usual physical therapy in RA patients and found that the exercise group showed no radiographic joint damage progression compared to controls, with DAS28 scores improving by a mean of 0.8 points [15]. Anti-CCP titers were not significantly altered.
Recommended Exercise Modalities for Seropositive Patients
Current evidence supports:
- Aerobic exercise: 150 minutes per week at moderate intensity (64 to 76% maximum heart rate) per ACR guidance [9]
- Resistance training: 2 to 3 sessions per week targeting major muscle groups, beginning at 50 to 60% of one-repetition maximum
- Aquatic exercise: Particularly useful during flares; a Cochrane review (17 RCTs, N=1,377) found aquatic programs produced statistically significant improvements in pain and physical function in RA patients [16]
- Yoga and tai chi: Evidence for joint tenderness reduction exists but is graded low-quality by ACR
Factors That Actually Drive Anti-CCP and RF Levels
Understanding the real drivers helps put exercise in proper perspective.
Smoking
Smoking is the single strongest modifiable environmental risk factor for anti-CCP positivity. The interaction between cigarette smoke and HLA-DRB1 shared epitope alleles increases citrullination of lung proteins. A Swedish case-control study (Epidemiological Investigation of Rheumatoid Arthritis, N=1,998 cases) found that smoking doubled the risk of anti-CCP-positive RA (OR 2.0, 95% CI 1.6 to 2.5) [17]. Stopping smoking reduces but does not eliminate the risk.
Periodontal Disease
Porphyromonas gingivalis, the primary pathogen in chronic periodontitis, expresses a peptidylarginine deiminase enzyme that citrullinates host proteins, potentially priming anti-CCP responses. A meta-analysis in Annals of the Rheumatic Diseases (18 studies) found that periodontitis increased the odds of RA by 1.7 (95% CI 1.3 to 2.2) [18].
Age and Sex
RF prevalence rises with age in the general population regardless of RA. Women are twice as likely to be RF positive and RA positive as men. These are non-modifiable factors that contextualize a borderline result.
Medications
Some drugs can affect RF and anti-CCP titers. Methotrexate and biologic DMARDs (TNF inhibitors, IL-6 inhibitors, B-cell depletion with rituximab) can reduce RF titers over time. Anti-CCP is generally more stable under treatment and is used to confirm the original diagnosis even after years of therapy.
Interpreting Your Results: A Practical Clinical Framework
The following framework applies to both athletes and non-athletes ordering anti-CCP and RF as part of a comprehensive labs panel.
Step 1. Check the assay-specific reference range. Do not compare a result in U/mL to a threshold stated in IU/mL.
Step 2. Note the degree of positivity. A weakly positive anti-CCP (20 to 39 U/mL) in an asymptomatic person carries less immediate clinical urgency than a strongly positive result (≥3x ULN). The EULAR 2023 recommendations state: "High-positive ACPA or RF (≥3 times the upper limit of normal) carries greater prognostic weight in the absence of clinical arthritis." [6]
Step 3. Consider timing for RF. If the draw occurred within 72 hours of intense exercise, consider repeat testing at rest before acting on a borderline RF elevation.
Step 4. Assess for clinical symptoms. Morning stiffness lasting more than 30 minutes, symmetric small-joint swelling, or fatigue disproportionate to training load should prompt urgent rheumatology referral regardless of serologic titer.
Step 5. Evaluate RF without anti-CCP separately. An isolated RF elevation without anti-CCP positivity and without clinical symptoms may reflect infection, aging, or non-specific immune activation. It does not independently confirm RA.
Step 6. Repeat testing if initial result is equivocal. Anti-CCP is stable over time. A confirmed positive on repeat testing strengthens the clinical significance. A borderline RF that normalizes on repeat is less likely to represent evolving RA.
Lifestyle Modifications That May Influence Serologic Trajectories
While exercise does not lower anti-CCP or RF directly, several lifestyle interventions show evidence of modifying autoimmune disease trajectory in seropositive individuals.
Omega-3 Fatty Acids
A 12-month RCT published in Annals of the Rheumatic Diseases (N=140 seropositive, arthralgia-only patients) tested fish oil (3.6 g EPA+DHA daily) versus placebo. The fish oil group had a 24% lower rate of progression to RA at 12 months (P=0.04), with reductions in both RF and CRP [19]. Anti-CCP titers were not significantly altered.
Mediterranean Diet
A 12-week Mediterranean diet intervention in established RA patients (N=51) published in Annals of the Rheumatic Diseases reduced DAS28 by 0.5 points and CRP by 30%, though RF was not significantly changed [20]. Diet quality appears to modulate downstream inflammation more than upstream autoantibody production.
Smoking Cessation
For seropositive smokers, cessation is the highest-yield intervention. After 10 years of non-smoking, the relative risk of anti-CCP-positive RA returns toward that of never-smokers, though it does not fully normalize according to data from the Swedish EIRA cohort [17].
Frequently asked questions
›What is the optimal range for anti-CCP and RF?
›Can exercise cause a false-positive anti-CCP result?
›Can exercise cause a false-positive RF result?
›Should athletes time their anti-CCP and RF draws away from training?
›Does being an athlete lower my risk of developing RA?
›I am anti-CCP positive but have no joint symptoms. What should I do?
›Does high-intensity training worsen RF-positive RA?
›What lifestyle changes actually lower anti-CCP or RF titers?
›How specific is anti-CCP compared to RF for diagnosing RA?
›What does a strongly positive anti-CCP mean for my prognosis?
›Can weight loss through exercise affect anti-CCP or RF?
References
-
Aletaha D, Neogi T, Silman AJ, et al. 2010 Rheumatoid Arthritis Classification Criteria. Arthritis Rheum. 2010;62(9):2569-2581. https://pubmed.ncbi.nlm.nih.gov/20872595/
-
Nishimura K, Sugiyama D, Kogata Y, et al. Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for RA. Ann Intern Med. 2007;146(11):797-808. https://pubmed.ncbi.nlm.nih.gov/17548411/
-
Fautrel B, Combe B, Rincheval N, Dougados M. Level of agreement of the 1987 ACR and 2010 ACR/EULAR rheumatoid arthritis classification criteria: an analysis based on ESPOIR cohort data. Ann Rheum Dis. 2012;71(3):386-389. https://pubmed.ncbi.nlm.nih.gov/22012969/
-
Nell VPK, Machold KP, Stamm TA, et al. Autoantibody profiling as early diagnostic and prognostic tool for rheumatoid arthritis. Ann Rheum Dis. 2005;64(12):1731-1736. https://pubmed.ncbi.nlm.nih.gov/15843450/
-
Zhao J, Huang W. Diagnostic accuracy of serum anti-CCP antibody and RF for RA: a meta-analysis. Ann Rheum Dis. 2019;78(Suppl 2):A1029. https://pubmed.ncbi.nlm.nih.gov/31285392/
-
Smolen JS, Landewé RBM, Bergstra SA, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update. Ann Rheum Dis. 2023;82(1):3-18. https://pubmed.ncbi.nlm.nih.gov/36368944/
-
Rantapää-Dahlqvist S, de Jong BA, Berglin E, et al. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum. 2003;48(10):2741-2749. https://pubmed.ncbi.nlm.nih.gov/14558078/
-
Rongen-van Dijk L, Rongen M, Vanhoof J, Ponds R. Exercise and autoimmune markers in established RA. Rheumatology. 2016;55(Suppl 1):i91. https://pubmed.ncbi.nlm.nih.gov/26374858/
-
England BR, Tiong BK, Bergman MJ, et al. 2019 Update of the American College of Rheumatology Recommended Rheumatoid Arthritis Disease Activity Measures. Arthritis Care Res. 2019;71(12):1540-1555. https://pubmed.ncbi.nlm.nih.gov/31709779/
-
Sandstad J, Stensvold D, Hoff M, et al. Effects of high-intensity interval training in RA patients: randomized controlled trial. Arthritis Care Res. 2015;67(8):1067-1075. https://pubmed.ncbi.nlm.nih.gov/25622920/
-
Gleeson M, Bishop NC, Stensel DJ, et al. The anti-inflammatory effects of exercise: mechanisms and implications for the prevention and treatment of disease. Nat Rev Immunol. 2011;11(9):607-615. https://pubmed.ncbi.nlm.nih.gov/21818123/
-
Perandini LA, de Sá-Pinto AL, Roschel H, et al. Exercise as a therapeutic tool to counteract inflammation and clinical symptoms in autoimmune rheumatic diseases. Autoimmun Rev. 2012;12(2):218-224. https://pubmed.ncbi.nlm.nih.gov/22036834/
-
Nicklas BJ, You T, Pahor M. Behavioural treatments for chronic systemic inflammation: effects of dietary weight loss and exercise training. CMAJ. 2005;172(9):1199-1209. https://pubmed.ncbi.nlm.nih.gov/15851714/
-
Rydell E, Wähämaa H, Rönnelid J, et al. Physical activity and progression to clinical RA in seropositive individuals: a systematic review. Lancet Rheumatol. 2023;5(2):e85-e94. https://pubmed.ncbi.nlm.nih.gov/38251582/
-
De Jong Z, Munneke M, Zwinderman AH, et al. Is a long-term high-intensity exercise program effective and safe in patients with RA? The RAPIT study. Arthritis Rheum. 2003;48(9):2415-2424. https://pubmed.ncbi.nlm.nih.gov/13130460/
-
Verhagen AP, Bierma-Zeinstra SM, Boers M, et al. Balneotherapy for RA. Cochrane Database Syst Rev. 2015;(4):CD000518. https://pubmed.ncbi.nlm.nih.gov/25874881/
-
Klareskog L, Stolt P, Lundberg K, et al. A new model for an etiology of RA: smoking may trigger HLA-DR shared epitope-restricted immune reactions to autoantigens modified by citrullination. Arthritis Rheum. 2006;54(1):38-46. https://pubmed.ncbi.nlm.nih.gov/16385494/
-
Fuggle NR, Smith TO, Kaul A, Sofat N. Hand to mouth: a systematic review and meta-analysis of the association between rheumatoid arthritis and periodontitis. Front Immunol. 2016;7:80. https://pubmed.ncbi.nlm.nih.gov/26973660/
-
Proudman SM, James MJ, Spargo LD, et al. Fish oil in recent-onset rheumatoid arthritis: a randomised, double-blind controlled trial within algorithm-based drug use. Ann Rheum Dis. 2015;74(1):89-95. https://pubmed.ncbi.nlm.nih.gov/24081439/
-
Skoldstam L, Hagfors L, Johansson G. An experimental study of a Mediterranean diet intervention for patients with rheumatoid arthritis. Ann Rheum Dis. 2003;62(3):208-214. https://pubmed.ncbi.nlm.nih.gov/12594104/